Engineered Plasmodium parasites form the basis of two experimental malaria vaccines that showed safety and encouraging immune responses in clinical trials.

The study, conducted in Malawi, Kenya, and Ghana, did not obtain informed consent from each parent whose child participated, but rather considered consent “implied” because of the particular experimental design.

The World Health Organization and its partners will test the public health effect of immunization in parts of Malawi, Ghana, and Kenya.

The parasite that causes malaria has evolved to evade many of the drugs that researchers have developed to fight the tropical disease.

Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.

The large-scale experiments aim to test how the technology would fare in the wild, if deployed to knock down populations of the pests.

Researchers used the genome sequence of Artemisia annua to boost the plant’s production of artemisinin.

The parasite changes people’s scent, primarily due to an increase in aldehydes.

Geckos could help control mosquito-borne diseases, but their effectiveness depends on the environment.